Mateon Therapeutics (MATN) Short Interest Ratio & Short Volume

Short interest is the volume of Mateon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 3,700 shares of MATN short. Learn More on Mateon Therapeutics' current short interest.

Mateon Therapeutics saw a decline in short interest in March. As of March 15th, there was short interest totaling 3,700 shares, a decline of 93.0% from the previous total of 52,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Mateon Therapeutics: Phio Pharmaceuticals Corp. (0.47%), Atreca, Inc. (0.37%), Revelation Biosciences, Inc. (8.34%), Appili Therapeutics Inc. (0.10%), Aravive, Inc. (1.81%), GeoVax Labs, Inc. (0.31%), Vivesto AB (0.00%), 60 Degrees Pharmaceuticals, Inc. (0.75%), Virpax Pharmaceuticals, Inc. (3.42%), Mustang Bio, Inc. (2.35%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.63 billion), Charter Communications, Inc. ($5.41 billion), Analog Devices, Inc. ($5.32 billion), Baidu, Inc. ($4.45 billion), Snap Inc. ($3.86 billion), Warner Bros. Discovery, Inc. ($3.30 billion), Airbnb, Inc. ($2.82 billion), Bilibili Inc. ($2.34 billion), GameStop Corp. ($2.24 billion), and Expedia Group, Inc. ($2.21 billion). View all of the most shorted stocks.

Short selling MATN is an investing strategy that aims to generate trading profit from Mateon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Mateon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MATN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MATN, twice per month. The most recent reporting period available is March, 15 2021.